marketcaparena

MOBI

Mobia Medical, Inc.

Company overview

Market capitalization
$293.96M
Employees
167
Latest publication
2026-09-29
About Mobia Medical, Inc.

Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions. The company provides neurostimulation systems and devices that combine vagus nerve stimulation with therapy to address chronic neurological conditions. Its main product, the Vivistim System, is an FDA-approved implantable device designed to aid in the rehabilitation of upper limb motor function in post-stroke patients. The paired VNS platform is used to help patients relearn movements and improve motor deficits, and it is being developed for additional chronic neurologic conditions such as tinnitus. The company supports healthcare professionals, patients, and caregivers with information and resources related to its offerings. The company serves healthcare professionals and organizations involved in stroke rehabilitation and chronic neurological conditions, as well as patients and caregivers within the healthcare sector. The company was founded in 2007 and is based in Austin, Texas.

Company website

Financial statements

Income Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USD
Total Revenue13,505,000USD
Cost Of Revenue2,267,000USD
Gross Profit11,238,000USD
Research Development2,278,000USD
Selling General Administrative26,886,000USD
Total Operating Expenses29,164,000USD
Operating Income-17,926,000USD
Total Other Income Expense Net-3,115,000USD
Interest Expense254,000USD
Income Before Tax-21,041,000USD
Income Tax Expense2,000USD
Net Income-21,043,000USD
Net Income Applicable To Common Shares-21,043,000USD
SourceDisclosureDeterministicFinal

Income Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USD
Total Revenue32,040,978USD15,644,398USD
Cost Of Revenue6,065,955USD3,193,173USD
Gross Profit25,975,023USD12,451,225USD
Research Development6,515,249USD4,243,399USD
Selling General Administrative65,827,675USD32,444,116USD
Unclassified Operating Expenses6,065,955USD3,193,173USD
Total Operating Expenses78,408,879USD39,880,688USD
Operating Income-46,367,901USD-24,236,290USD
Interest Expense967,368USD969,920USD
Net Interest Income-967,368USD-969,920USD
Income Before Tax-46,492,738USD-24,589,101USD
Tax Provision5,450USD13,913USD
Net Income-46,498,188USD-24,603,014USD
Net Income From Continuing Ops-46,498,188USD-24,603,014USD
Reconciled Depreciation151,657USD116,010USD
Total Other Income Expense Net842,531USD617,109USD
SourceLegacy providerLegacyLegacy providerLegacy

Balance sheet Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USD
Total Assets195,284,000USD
Cash And Equivalents177,090,000USD
Total Current Assets192,149,000USD
Other Current Assets2,446,000USD
Other Non Current Assets143,000USD
Total Liabilities22,675,000USD
Total Current Liabilities14,472,000USD
Total Stockholder Equity172,609,000USD
Total Equity Including Noncontrolling Interest172,609,000USD
Net Receivables5,664,000USD
Inventory6,949,000USD
Property Plant Equipment Net2,992,000USD
Accounts Payable2,359,000USD
Short Term Debt358,000USD
Common Stock333,000USD
Retained Earnings-196,572,000USD
SourceDisclosureDeterministicFinal

Balance sheet Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USD
Total Assets48,148,699USD22,091,037USD
Other Current Assets1,942,958USD299,023USD
Total Liab198,922,286USD128,126,840USD
Total Stockholder Equity-150,773,587USD-106,035,803USD
Other Current Liab1,323,498USD499,534USD
Capital Stock8,840USD7,767USD
Retained Earnings-157,789,133USD-111,290,945USD
Cash33,587,308USD14,620,320USD
Total Current Assets46,357,242USD21,174,741USD
Total Current Liabilities10,206,207USD4,596,806USD
Long Term Debt7,129,928USD7,094,070USD
Net Receivables4,435,223USD2,826,236USD
Inventory5,456,757USD3,429,162USD
Accounts Payable2,222,970USD1,139,326USD
Property Plant Equipment Net1,737,582USD894,964USD
Property Plant Equipment Gross2,041,987USD1,120,933USD
Common Stock Shares Outstanding33,085,391shares33,085,391shares
Non Current Assets Total1,791,457USD916,296USD
Non Current Liabilities Total188,716,079USD123,530,034USD
Non Currrent Assets Other53,875USD21,332USD
Net Working Capital36,151,035USD16,577,935USD
Unclassified Current Liabilities6,659,739USD2,957,946USD
Unclassified Non Current Liabilities181,586,151USD116,435,964USD
Unclassified Equity7,006,706USD5,247,375USD
SourceLegacy providerLegacyLegacy providerLegacy

Cash flow Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USD
Net Income-46,498,188USD-24,603,014USD
Depreciation151,657USD116,010USD
Stock Based Compensation1,446,702USD758,127USD
Other Non Cash Items270,474USD48,297USD
Change To Account Receivables-1,608,987USD-1,386,950USD
Change To Inventory-2,027,595USD-245,409USD
Change In Working Capital-923,683USD-634,721USD
Total Cash From Operating Activities-45,694,990USD-24,315,301USD
Capital Expenditures-364,411USD-40,848USD
Free Cash Flow-46,059,401USD-24,356,149USD
Total Cash From Financing Activities65,026,389USD15,658,269USD
Issuance Of Capital Stock64,712,687USD14,986,642USD
Change In Cash18,966,988USD-8,697,880USD
Begin Period Cash Flow14,620,320USD23,318,200USD
End Period Cash Flow33,587,308USD14,620,320USD
SourceLegacy providerLegacyLegacy providerLegacy

Operating metrics

No operating metrics are currently published for this company.

Revenue breakdown

No revenue breakdown is currently published for this company.

Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.